|
|
|
||||
|
|
|||||
|
Computerized results of Menopause Type® Questionnaire: |
|
||||
|
Menopause Type® Eleven |
|||||
|
Menopause
Type® Eleven has
symptoms that reveal decreased
estrogen function, decreased progesterone function, and decreased testosterone function.
Health risks associated with Menopause
Type® Eleven may include vulvar disorders, decreased muscle
mass, depression, osteoporosis and heart disease, including angina pectoralis
(chest pain). Since estradiol deficiency can affect
blood glucose metabolism, there is also increased risk of insulin resistance
and blood sugar disorders. Risks associated with insulin resistance include
increased risk of heart disease, diabetes and endometrial cancer. |
See Pages
155-162 |
||||
|
PROTOCOL: The following protocol provides women with
Menopause Type® 11 information on which nutritional and herbal
formulations can support the normal function of hormone responsive tissues.
Please review the Advanced
Integrative Management of Menopause document for more
detailed information. |
|||||
|
Foundational Interventions: |
|||||
|
Foundational interventions include lifestyle and dietary choices that support optimal hormone function. In addition, a high grade multiple vitamin mineral formulation rich in antioxidants and essential fatty acids rich in docosahexaenoic acid are required for optimal hormone function. |
|||||
|
Ultra Preventive® X V-Cap - A high grade multiple
vitamin and mineral supplement with significant antioxidant support. Vitamins
and minerals are cofactors required
for every biochemical process in the human body, including the production and
proper detoxification of hormones. Oxygen stress contributes to some of the
pathophysiolgical effects of suboptimal menopause. These effects may be
prevented and/or treated by improving the antioxidant defense of
perimenopause, menopause, and postmenopausal women. |
|||||
|
Opti DHA - An essential fatty acid
rich in docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), with a
high DHA:EPA ratio. The essential fatty acid DHA help maintain ideal cell membrane
fluidity allowing optimal transport of molecules across the membrane, which
is critical for hormone function, while EPA helps the body control
inflammation. |
|||||
|
Primary Endocrine Formulations : |
|||||
|
Primary Endocrine Nutraceutical formulations should be used to support the function of hormone producing glands and hormone responsive tissues. The primary formulations that are appropriate to manage hormonal imbalances observed in Menopause Type® Eleven include: |
|||||
|
Estro-Mend™ is a unique blend of isoflavones, phytoestrogens and other herbs to naturally support hormonal balance by supporting the ideal function of estrogen responsive tissues as needed in Menopause Type® Eleven. More Information Estro-Mend™ |
|||||
|
Progesto-Mend™ is a unique blend of phytoprogesterones, adaptogens and other herbs to naturally support hormonal balance by supporting the ideal function of progesterone producing tissues and of progesterone responsive tissues as needed in Menopause Type® Eleven. More Information on Progesto-Mend™ |
|||||
|
Testo-Gain™, a unique blend of phytoandrogens, adaptogens and other herbs to naturally support hormonal balance by supporting the ideal function of testosterone producing tissues and of testosterone responsive tissues as needed in Menopause Type® Eleven. More Information on Testo-Gain™ |
|||||
|
Please Find a Healthcare Professional in your area to customize these protocols. |
|||||
|
Secondary Endocrine Formulations: |
|||||
|
Since decreased thyroid function can
adversely affect the function of other hormones, a nutraceutical formulation to support the function
of the thyroid gland and the liver (which converts T4 to T3)
and also supports the function and response of tissues that respond to
thyroid hormones should be used if there are signs and symptoms of decreased thyroid function. As noted, there may be decreased blood glucose function in Menopause Type® Eleven due to the primary hormone imbalances. Excessive body weight also increases the risk for decreased blood glucose function. A nutraceutical formulation to support healthy blood glucose function should be used if there are signs and symptoms of decreased blood sugar function |
|||||
|
Thyro-Mend™ is a synergistic combination of iodine containing seaweeds, and herbs which contain phytothyroidogenic, phyto-thyroid-receptor agonists, and other herbs designed to promote optimal function of thyroid hormones by maintaining the health of thyroid hormone producing tissues and by supporting the healthy function of tissues that respond to thyroid hormones. More information on Thyro-Mend™. |
|||||
|
Glucobrium is a synergistic formulation of phytotherapeutic extracts which mimic and potentiate the actions of insulin and support healthy blood glucose function. More information on Glucobrium. |
|||||
|
When to Consider
Hormone Precursors & Bioidentical Hormone Replacement Therapy |
|||||
|
Hormone precursors such as Pregnenolone 25 Mg Tab, DHEA 5 MG and 7-KETO may be used to support hormone production pathways that create
progesterone, testosterone and estrogens. They have mild hormone actions in
and of themselves, and do not have the same risks that are associated with
Hormone Replacement Therapies (HRT). Bioidentical Hormone Replacement Therapy (BHRT), while considered more
appropriate than synthetic hormone therapies, does not support the hormone production
pathways, but instead provides “replacement”, which may further diminish
endogenous hormone production. Evaluation
of hormone levels, use of hormone precursors as needed, and as a final course of action, the prescription
of bioidentical hormone therapies should be considered only when
restoration of normal function is not possible. |
|||||
|
Also Review: |
|||||
|
Make the Right Choice |
|||||
|
Work with a Healthcare Professional
in your area: Find a healthcare professional in your area who has shown
such commitment as to take an extensive course of study on menopause type®
management, including nutritional, herbal & natural hormone therapies. Please go to Find a Healthcare Professional . |
|||||
|
How Your
Menopause Type® Was Calculated
(www.YourMenopauseType.com/Questionnaire.html#Calculate) |
|||||
|
|
|||||
|
♦These statements have not been evaluated by the
Food and Drug Administration. |
|||||
|
Review Disclaimer & Legal
(www.YourMenopauseType.com/Disclaimer) |
|||||
YourMenopauseType.com,
Inc.
|
|||||
|
Last update
03/18/07 |
|||||
|
|
|||||